Griseofulvin contraindications: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) (Created page with "__NOTOC__ {{Griseofulvin}} {{CMG}}; {{AE}} {{AZ}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = GRIFULVIN V (GRISEOFULVIN) TABLET [ORTHO-MCNEIL...") |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
==Contraindications== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = GRIFULVIN V (GRISEOFULVIN) TABLET [ORTHO-MCNEIL PHARMACEUTICALS] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b876327f-d496-46a7-ae39-011baaad6aa7 | publisher = | date = | accessdate = }}</ref> | The drug is contraindicated in patients with [[porphyria]], hepatocellular failure, and in individuals with a history of hypersensitivity to griseofulvin. | ||
Two cases of conjoined twins have been reported in patients taking griseofulvin during the first trimester of pregnancy. Griseofulvin '''should not''' be prescribed to pregnant patients.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = GRIFULVIN V (GRISEOFULVIN) TABLET [ORTHO-MCNEIL PHARMACEUTICALS] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b876327f-d496-46a7-ae39-011baaad6aa7 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 23:11, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Contraindications
The drug is contraindicated in patients with porphyria, hepatocellular failure, and in individuals with a history of hypersensitivity to griseofulvin.
Two cases of conjoined twins have been reported in patients taking griseofulvin during the first trimester of pregnancy. Griseofulvin should not be prescribed to pregnant patients.[1]
References
Adapted from the FDA Package Insert.